antiviral kinase (Origenis)

N/A

Report date: 2025/01/26 16:48:09
NME

Base Information

Drug Nameantiviral kinase (Origenis)
Drug Alias Nameantiviral kinase (Origenis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases modulators
TargetsProtein kinases
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Virus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrigenis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesOrigenis GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Virus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A